Primary Immunodeficiency Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)
Condition: Primary Immunodeficiency Diseases (PID) Intervention: Drug: TAK-771 Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials
